VitaNova Life Sciences Corporation (VNOV)

VitaNova Life Sciences Revenue

In the fiscal year ending April 30, 2026, VitaNova Life Sciences had annual revenue of $3.03M with 13.65% growth. VitaNova Life Sciences had revenue of $1.78M in the quarter ending April 30, 2026, a decrease of -8.62%.

• Revenue: 3.03M
• Revenue Growth: +13.65%
• P/S Ratio: 6.56
• Revenue / Employee: 432.22K
• Employees: 7
• Market Cap: 19.84M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Apr 30, 2026	3.03M	363.43K	13.65%
Apr 30, 2025	2.66M	2.09M	366.47%
Apr 30, 2024	570.69K	532.69K	1,401.83%
Apr 30, 2023	38.00K	-82.00K	-68.33%
Apr 30, 2022	120.00K	-	-

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 8, 2026

Data Sources Report a data error